Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add more filters










Publication year range
1.
Pediatr Surg Int ; 28(1): 71-3, 2012 Jan.
Article in English | MEDLINE | ID: mdl-21656170

ABSTRACT

The Nuss procedure is the most popular technique for correction of pectus excavatum recently. Life-threatening complications associated with the procedure are very rare. We report a 13-year-old boy who developed late-onset bilateral hemothorax with hypovolemic shock 5 months after the Nuss procedure. In literature review, this is the first case of the late-onset life-threatening bilateral hemothorax with hypovolemic shock ever reported.


Subject(s)
Funnel Chest/surgery , Orthopedic Procedures/adverse effects , Pneumothorax/etiology , Adolescent , Fluid Therapy , Follow-Up Studies , Humans , Male , Pneumothorax/diagnosis , Pneumothorax/therapy , Postoperative Complications , Radiography, Thoracic , Thoracostomy , Time Factors
3.
Article in English | MEDLINE | ID: mdl-18023566

ABSTRACT

Numerous studies on perinatal long-chain polyunsaturated fatty acid nutrition have clarified the influence of dietary docosahexaenoic acid (DHA) and arachidonic acid (ARA) on central nervous system PUFA concentrations. In humans, omnivorous primates, and piglets, DHA and ARA plasma and red blood cells concentrations rise with dietary preformed DHA and ARA. Brain and retina DHA are responsive to diet while ARA is not. DHA is at highest concentration in cells and tissues associated with high energy consumption, consistent with high DHA levels in mitochondria and synaptosomes. DHA is a substrate for docosanoids, signaling compounds of intense current interest. The high concentration in tissues with high rates of oxidative metabolism may be explained by a critical role related to oxidative metabolism.


Subject(s)
Arachidonic Acid/pharmacology , Central Nervous System/drug effects , Docosahexaenoic Acids/pharmacology , Fatty Acids/metabolism , Animals , Arachidonic Acid/administration & dosage , Central Nervous System/metabolism , Dietary Fats, Unsaturated/administration & dosage , Dietary Fats, Unsaturated/pharmacology , Docosahexaenoic Acids/administration & dosage , Fatty Acids/chemistry , Humans
4.
Pediatr Surg Int ; 23(11): 1119-21, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17828406

ABSTRACT

The authors developed a preputial skin flap technique to correct the buried penis which was simple and practical. This simple procedure can be applied to most boys with buried penis. In the last 3 years, we have seen 12 boys with buried penis and have been treated by using preputial flaps. The mean age is about 5.1 (from 3 to 12). By making a longitudinal incision on the ventral side of penis, the tightness of the foreskin is released and leave a diamond-shaped skin defect. It allows the penile shaft to extend out. A circumferential incision is made about 5 mm proximal to the coronal sulcus. Pedicled preputial flaps are obtained leaving optimal penile skin on the dorsal side. The preputial skin flaps are rotated onto the ventral side and tailored to cover the defect. All patients are followed for at least 3 months. Edema and swelling on the flaps are common, but improves with time. None of our patients need a second operation. The preputial flaps technique is a simple technique which allows surgeons to deal with most cases of buried penis by tailoring the flaps providing good cosmetic and functional results.


Subject(s)
Foreskin/surgery , Penile Diseases/surgery , Penis/abnormalities , Surgical Flaps , Urologic Surgical Procedures, Male/methods , Child , Child, Preschool , Follow-Up Studies , Humans , Male , Penile Diseases/congenital , Penis/surgery , Retrospective Studies , Treatment Outcome
5.
J Formos Med Assoc ; 106(5): 400-2, 2007 May.
Article in English | MEDLINE | ID: mdl-17561476

ABSTRACT

We report herein a case of a male newborn with a sacrococcygeal fetiform teratoma (FT). The baby presented with a large coccygeal teratoma. The preoperative diagnosis of FT was made by plain radiography, ultrasonography and magnetic resonance imaging. The baby was successfully treated by complete excision and pelvic floor reconstruction. Postoperative follow-up was uneventful until the teratoma recurred 11 months later as a malignancy. After undergoing a second operative procedure accompanied by chemotherapy, he has been doing well for 18 months.


Subject(s)
Cell Transformation, Neoplastic/pathology , Fetus/abnormalities , Neoplasms, Germ Cell and Embryonal/pathology , Sacrococcygeal Region , Teratoma/diagnosis , Teratoma/pathology , Adult , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Bleomycin/administration & dosage , Chemotherapy, Adjuvant , Cisplatin/administration & dosage , Etoposide/administration & dosage , Female , Humans , Infant, Newborn , Male , Neoplasms, Germ Cell and Embryonal/drug therapy , Neoplasms, Germ Cell and Embryonal/surgery , Pregnancy , Reoperation , Teratoma/drug therapy , Teratoma/surgery , Treatment Outcome , alpha-Fetoproteins/analysis
6.
J Formos Med Assoc ; 104(6): 441-3, 2005 Jun.
Article in English | MEDLINE | ID: mdl-16037836

ABSTRACT

Antenatal identification of choledochal cysts has become increasingly common with advances in prenatal ultrasonography. However, the antenatal diagnosis needs to be confirmed postnatally and a preoperative radiologic evaluation of the cyst prior to complete resection is required. There have been few reports of the application of magnetic resonance cholangiopancreatography in neonates, or in neonates with large choledochal cysts. We describe a neonate with a progressively growing giant choledochal cyst, which was initially detected at 28 weeks' gestation. After delivery, the baby did not feed well and suffered from jaundice and frequent postprandial bilious vomiting. At the age of 11 days, magnetic resonance cholangiopancreatography was used to confirm the prenatal diagnosis and provide a thorough preoperative evaluation. He underwent early resection of the cyst at 15 days of age and recovered uneventfully. Magnetic resonance cholangiopancreatography is an alternative diagnostic method for confirming the antenatal diagnosis of large choledochal cysts in neonates. It may also provide useful diagnostic information for preoperative evaluation.


Subject(s)
Cholangiopancreatography, Magnetic Resonance , Choledochal Cyst/diagnosis , Choledochal Cyst/surgery , Humans , Infant, Newborn , Male
7.
BMC Med ; 3: 11, 2005 Jun 23.
Article in English | MEDLINE | ID: mdl-15975147

ABSTRACT

BACKGROUND: Docosahexaenoic acid (DHA) and arachidonic acid (ARA) are major components of the cerebral cortex and visual system, where they play a critical role in neural development. We quantitatively mapped fatty acids in 26 regions of the four-week-old breastfed baboon CNS, and studied the influence of dietary DHA and ARA supplementation and prematurity on CNS DHA and ARA concentrations. METHODS: Baboons were randomized into a breastfed (B) and four formula-fed groups: term, no DHA/ARA (T-); term, DHA/ARA supplemented (T+); preterm, no DHA/ARA (P-); preterm and DHA/ARA supplemented (P+). At four weeks adjusted age, brains were dissected and total fatty acids analyzed by gas chromatography and mass spectrometry. RESULTS: DHA and ARA are rich in many more structures than previously reported. They are most concentrated in structures local to the brain stem and diencephalon, particularly the basal ganglia, limbic regions, thalamus and midbrain, and comparatively lower in white matter. Dietary supplementation increased DHA in all structures but had little influence on ARA concentrations. Supplementation restored DHA concentrations to levels of breastfed neonates in all regions except the cerebral cortex and cerebellum. Prematurity per se did not exert a strong influence on DHA or ARA concentrations. CONCLUSION: 1) DHA and ARA are found in high concentration throughout the primate CNS, particularly in gray matter such as basal ganglia; 2) DHA concentrations drop across most CNS structures in neonates consuming formulas with no DHA, but ARA levels are relatively immune to ARA in the diet; 3) supplementation of infant formula is effective at restoring DHA concentration in structures other than the cerebral cortex. These results will be useful as a guide to future investigations of CNS function in the absence of dietary DHA and ARA.


Subject(s)
Arachidonic Acid/metabolism , Central Nervous System/metabolism , Docosahexaenoic Acids/metabolism , Infant Formula/pharmacology , Animal Feed , Animals , Animals, Newborn , Arachidonic Acid/administration & dosage , Docosahexaenoic Acids/administration & dosage , Fatty Acids/metabolism , Female , Food, Fortified , Lactation , Papio , Random Allocation
8.
J Lipid Res ; 45(1): 71-80, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14523049

ABSTRACT

Infant formulas supplemented with docosahexaenoic acid (DHA) and arachidonic acid (ARA) are now available in the United States; however, little is known about the factors that affect biosynthesis. Baboon neonates were assigned to one of four treatments: term, breast-fed; term, formula-fed; preterm (155 of 182 days gestation), formula-fed; and preterm, formula+DHA/ARA-fed. Standard formula had no DHA/ARA; supplemented formula had 0.61%wt DHA (0.3% of calories) and 1.21%wt ARA (0.6% of calories), and baboon breast milk contained 0.68 +/- 0.22%wt DHA and 0.62 +/- 0.12%wt ARA. At 14 days adjusted age, neonates received a combined oral dose of [U-13C]alpha-linolenic acid (LNA*) and [U-13C]linoleic acid (LA*), and tissues were analyzed 14 days after dose. Brain accretion of linolenic acid-derived DHA was approximately 3-fold greater for the formula groups than for the breast-fed group, and dietary DHA partially attenuated excess DHA synthesis among preterms. A similar, significant pattern was found in other organs. Brain linoleic acid-derived ARA accretion was significantly greater in the unsupplemented term group but not in the preterm groups compared with the breast-fed group. These data show that formula potentiates the biosynthesis/accretion of DHA/ARA in term and preterm neonates compared with breast-fed neonates and that the inclusion of DHA/ARA in preterm formula partially restores DHA/ARA biosynthesis to lower, breast-fed levels. Current formula DHA concentrations are inadequate to normalize long-chain polyunsaturated fatty acids synthesis to that of breast-fed levels.


Subject(s)
Animal Feed , Animals, Newborn/metabolism , Arachidonic Acid/biosynthesis , Docosahexaenoic Acids/metabolism , Gestational Age , Infant Formula/pharmacology , Papio/physiology , Animals , Body Weight , Brain/metabolism , Erythrocytes/metabolism , Female , Linear Models , Liver/metabolism , Male , Organ Size , Time Factors
9.
Eur J Nutr ; 42(5): 293-6, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14569408

ABSTRACT

BACKGROUND: Addition of highly polyunsaturated fatty acids to infant formulas raises the possibility of increased lipid peroxidation. AIM OF THE STUDY: We determined the effects of increasing levels of dietary docosahexaenoic acid (DHA) and arachidonic acid (AA) on lipid peroxidation and peroxidative potential in piglet tissues. METHODS: Four groups of piglets (n = 6) were bottle-fed a formula containing one of four treatments: no long chain fatty acid (Diet 0) and three different levels of DHA/AA at 1-fold (0.3 %/0.6% FA; Diet 1) 2-fold (0.6 %/1.2% FA; Diet 2) and 5-fold (1.5%/3% FA; Diet 5) concentration used in some human infant formulas, and all with equal amount of vitamin E (5.7 IU/ 100 kcal formula) for four weeks. RESULTS: There were no significant differences between the groups in conjugated diene and glutathione (GSH) levels in the liver, and thiobarbituric acid-reactive substance (TBARS) in plasma. TBARS levels of the erythrocyte membranes increased in a dose-dependent manner when in vitro oxidation was induced with 10 mM hydrogen peroxide (H(2)O(2)) for 30 minutes. The TBARS levels of the liver homogenates of the Diet 5 and Diet 2 groups were significantly different than those of the membranes of the Diet 0 group when the in vitro oxidation was induced with H(2)O(2). CONCLUSION: The results show that dietary vitamin E effectively prevented lipid peroxidation at the LCP concentrations investigated and suggest that levels presently in infant formulas are sufficient.


Subject(s)
Fatty Acids, Unsaturated/pharmacology , Lipid Peroxidation/drug effects , Analysis of Variance , Animals , Animals, Newborn , Antioxidants/administration & dosage , Antioxidants/metabolism , Arachidonic Acid/administration & dosage , Arachidonic Acid/pharmacology , Dietary Supplements , Docosahexaenoic Acids/administration & dosage , Docosahexaenoic Acids/pharmacology , Dose-Response Relationship, Drug , Erythrocytes/drug effects , Erythrocytes/metabolism , Fatty Acids, Unsaturated/administration & dosage , In Vitro Techniques , Liver/chemistry , Liver/drug effects , Liver/metabolism , Male , Swine , Thiobarbituric Acid Reactive Substances/metabolism , Vitamin E/administration & dosage
10.
Invest Ophthalmol Vis Sci ; 44(10): 4559-66, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14507905

ABSTRACT

PURPOSE: Dietary n-3 polyunsaturated fatty acid deficiency and prematurity are both associated with suboptimal visual function in nonhuman primates and in humans. This study reports measurements of retinal long chain polyunsaturate (LCP) concentrations and electroretinogram (ERG) parameters for term and preterm neonatal baboons consuming clinically relevant diets. METHODS: ERGs and retinal fatty acid compositions were obtained from baboon neonates in four groups: term-delivered/breast-fed (B), term/formula-fed (T-), preterm/formula-fed (P-), and preterm/formula (P+) supplemented with long chain polyunsaturates. Initial a-wave slope change (ä), a-wave amplitude (a(amp)) and implicit time (a(i)), and b-wave amplitude (b(amp)) and implicit time (b(i)) were determined and correlations to retinal fatty acid concentrations were evaluated. RESULTS: The P+ group ä and b(amp) significantly improved between 0 and 4 weeks' adjusted age, whereas no P- group parameter improved with age. At four weeks, both a(amp) and b(amp) were significantly greater in group B than in all other groups, and ä and a(i) were greater for P+ than for P-. Concentrations of 22:6n-3, 22:5n-3, and Sigman-3 and the 22:5n-6/22:6n-3 ratio correlated positively with improved retinal response parameters, whereas 22:5n-6, 22:4n-6, 20:4n-6, 20:3n-6, 20:2n-9, 20:1n-9, and 18:1n-9 all correlated negatively (P < 0.05); saturates were uncorrelated. The parameters most linearly related to retinal 22:6n-3 were ä, a(i), and a(amp). Retinal 20:4n-6 concentrations were not influenced by prematurity or supplementation. CONCLUSIONS: Breast-feeding optimizes retinal response in 4-week-old baboons. Formula supplemented with 22:6n-3 prevents a decrease in retinal 22:6n-3 and improves preterm ERG parameters compared with unsupplemented formula. Retinal 22:6n-3 status is most closely associated with a-wave parameters.


Subject(s)
Arachidonic Acids/administration & dosage , Docosahexaenoic Acids/administration & dosage , Retina/physiology , Animal Feed , Animals , Animals, Newborn/metabolism , Electroretinography , Fatty Acids/metabolism , Female , Male , Papio , Pregnancy
11.
Lipids ; 38(4): 425-9, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12848289

ABSTRACT

One of the major survival challenges of premature birth is production of lung surfactant. The lipid component of surfactant, dipalmitoyl PC (DPPC), increases in concentration in the period before normal term birth via a net shift in FA composition away from unsaturates. We investigated the influence of dietary DHA and arachidonic acid (AA) on lung FA composition and DPPC concentration in term and preterm baboons. Pregnant animals/neonates were randomized to one of four groups: breast-fed (B), term formula-fed (T-, preterm formula-fed (P-, and preterm fed formula supplemented with DHA-AA (P+). Breast milk contained 0.68%wt DHA and the P+ group formula contained 0.61%wt DHA. In the preterm groups (P- and P+), pregnant females received a course of antenatal corticosteroids. At the adjusted age of 4 wk, neonate lung tissue was harvested, and FA composition and DPPC were analyzed. Palmitate was approximately 28%wt of lung total FA and no significant differences were found among the four treatment groups. In contrast, DPPC in the B group lung tissue was significantly greater than DPPC in the unsupplemented groups, but not compared with the P+ group. The B and P+ groups were not significantly different in DHA and AA, but were different compared with the unsupplemented (T, P-) groups. These results indicate that LCP supplementation increases lung DHA and AA, without compromising overall lung 16:0 or DPPC. The shift in FA composition toward greater unsaturation in the groups consuming LCP supported improved surfactant lipid concentration in preterm neonate lungs.


Subject(s)
1,2-Dipalmitoylphosphatidylcholine/metabolism , Dietary Fats, Unsaturated/metabolism , Fatty Acids, Unsaturated/metabolism , Lung/metabolism , Papio/metabolism , Animals , Animals, Newborn , Dietary Fats, Unsaturated/administration & dosage , Fatty Acids/analysis , Fatty Acids/metabolism , Fatty Acids, Unsaturated/administration & dosage , Female , Milk/chemistry , Pregnancy
12.
Pediatr Res ; 54(2): 244-52, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12736388

ABSTRACT

Clinical studies show that docosahexaenoic acid (DHA) and arachidonic acid (ARA) supplemented formula improve visual function in preterm infants, however improved fatty acid status is known only for plasma and red blood cells (RBC) since target organs cannot be sampled from humans. Baboons were randomized to one of four groups: Term breast-fed (B); Term formula-fed (T-); Preterm formula-fed (P-); and Preterm DHA/ARA-supplemented formula-fed (P+). The P+ contained 0.61 +/- 0.03% DHA and 1.21 +/- 0.09% ARA, and breast milk had 0.68 +/- 0.22% and 0.62 +/- 0.12% as DHA and ARA, respectively. The B and P+ groups had significantly higher DHA concentration in all tissues than T- and P-. The P- group showed dramatically lower DHA content of 35%, 27%, 66%, and 75% in the brain, retina, liver, and plasma, respectively, compared with B. Supplementation prevented declines in DHA levels in the retina, and liver, and attenuated the decline in brain, plasma and RBC of preterm animals. In contrast, ARA was not significantly lower compared with B in any group in any tissue but was significantly elevated in liver and brain. RBC and plasma DHA were correlated with DHA in tissues; RBC/plasma ARA were uncorrelated with tissue ARA. We conclude that 1) DHA drops precipitously in term and preterm primates consuming formula without long chain polyunsaturates, while 22:5n-6 concentration rises; 2) tissue ARA levels are insensitive to dietary LCP supplementation or prematurity, 3) plasma and RBC levels of ARA are uncorrelated with total ARA levels; 4) DHA levels are correlated with group effects and are uncorrelated within groups.


Subject(s)
Arachidonic Acid/pharmacokinetics , Docosahexaenoic Acids/pharmacokinetics , Obstetric Labor, Premature , Visual Cortex/growth & development , Animals , Animals, Newborn , Arachidonic Acid/blood , Docosahexaenoic Acids/blood , Erythrocytes/metabolism , Fatty Acids, Monounsaturated/metabolism , Female , Liver/growth & development , Liver/metabolism , Papio , Pregnancy , Regression Analysis , Retina/growth & development , Retina/metabolism , Visual Cortex/metabolism
13.
Anal Biochem ; 307(2): 348-60, 2002 Aug 15.
Article in English | MEDLINE | ID: mdl-12202254

ABSTRACT

Double bond position in natural fatty acids is critical to biochemical properties, however, common instrument-based methods cannot locate double bonds in fatty acid methyl esters (FAME), the predominant analysis form of fatty acids. A recently described mass spectrometry (MS) method for locating double bonds in FAME is reported here for the analysis of minor (<1%) components of real FAME mixtures derived from three natural sources; golden algae (Schizochytrium sp.), primate brain white matter, and transgenic mouse liver. Acetonitrile chemical ionization tandem MS was used to determine double bond positions in 39 FAME, most at concentrations well below 1% of all fatty acid methyl esters. FAME identified in golden algae are 14:1n-6, 14:3n-3, 16:1n-7, 16:2n-6, 16:3n-6, 16:3n-3, 16:4n-3, 18:2n-7, 18:3n-7, 18:3n-8, 18:4n-3, 18:4n-5, 20:3n-7, 20:4n-3, 20:4n-5, 20:4n-7, 20:5n-3, and 22:4n-9. Additional FAME identified in primate brain white matter are 20:1n-7, 20:1n-9, 20:2n-7, 20:2n-9, 22:1n-7, 22:1n-9, 22:1n-13, 22:2n-6, 22:2n-7, 22:2n-9, 22:3n-6, 22:3n-7, 22:3n-9, 22:4n-6, 24:1n-7, 24:1n-9, and 24:4n-6. Additional FAME identified in mouse liver are 26:5n-6, 26:6n-3, 28:5n-6, and 28:6n-3. The primate brain 22:3n-7 and algae 18:4n-5 are novel fatty acids. These results demonstrate the usefulness of the technique for analysis of real samples. Tables are presented to aid in interpretation of acetonitrile CIMS/MS spectra.


Subject(s)
Acetonitriles/chemistry , Fatty Acids/analysis , Fatty Acids/chemistry , Mass Spectrometry/methods , Animals , Brain Chemistry , Eukaryota/chemistry , Liver/chemistry , Mice , Mice, Transgenic , Papio
14.
J Lipid Res ; 43(5): 762-7, 2002 May.
Article in English | MEDLINE | ID: mdl-11971947

ABSTRACT

Dietary arachidonic acid (20:4n-6) utilization in-vivo for carbon recycling into de-novo lipogenesis and conversion to n-6 long chain polyunsaturates was investigated in baboon neonates using [U-(13)C]20:4n-6. Neonates consuming a formula typical of human milk received a single oral dose of [(13)C]arachidonic acid in sn-2 position of either triglyceride or phosphatidylcholine at 18-19 days of postnatal life. Neonate brain, retina, liver, and plasma were obtained 10 days later (28-29 days of life). Low isotopic enrichment (0.27-1.0%Total label) was detected in dihomo-gamma-linolenic acid (20:3n-6) in all tissues, but label incorporation into saturates or monounsaturates was not detected. In neonate brain and retina, 16% and 11% of total label was recovered in 22:4n-6, respectively. The relative contribution of dietary fatty acids to postnatal brain 22:4n-6 accretion can be estimated for dietary 20:4n-6 and preformed 22:4n-6 as 17% and 8%, respectively, corresponding to efficiencies of 0.48% and 0.54% of dietary levels, respectively. These results demonstrate in term baboon neonates that in vivo 1) 20:4n-6 was retroconverted to 20:3n-6, 2) 20:4n-6 did not contribute significantly to de novo lipogenesis of saturates and monounsaturates, and 3) the preformed 20:4n-6 contribution to brain 22:4n-6 accumulation was quantitatively a significant metabolic fate for dietary 20:4n-6.


Subject(s)
Arachidonic Acid/metabolism , Brain/metabolism , Dietary Fats, Unsaturated/metabolism , Erucic Acids/metabolism , Animals , Animals, Newborn , Carbon Isotopes , Fatty Acids, Unsaturated , Female , Gestational Age , Humans , Isotope Labeling/methods , Milk, Human , Papio , Pregnancy
15.
Pediatr Res ; 51(3): 265-72, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11861929

ABSTRACT

Arachidonic acid (AA) is a long-chain polyunsaturate (LCP) present in human breast milk as both triglyceride (TG) and as phospholipid (PL). There has been little attention to the metabolic consequences of lipid form of AA in infant formulas. Our objective was to investigate the efficacy of dietary TG and PL as carriers of AA for accretion in the brain and associated organs of term baboon neonates consuming a formula with LCP composition typical of human milk. TG and phosphatidylcholine (PC) with [U-(13)C]-AA in the sn-2 position and with unlabeled 16:0 in the remaining positions (TG-AA* or PL-AA*, respectively) were used as tracers to study the tissue AA* incorporation. Baboon neonates received a single oral dose of either TG-AA* (n = 3) or PL-AA* (n = 4) at 18-19 d of life. Tissues were obtained 10 d later (28-29 d of life) and isotopic enrichment was measured. In the brain, 4.5% of the PL-AA* dose and 2.1% of the TG-AA* dose were recovered as brain AA*, respectively, indicating that PL was about 2.1-fold more effective than TG as a substrate for brain AA accretion. Preferential incorporation of PL-derived AA* over TG source of AA* was also observed in the liver, lung, plasma, and erythrocytes. Because of the quantitative predominance of TG-AA in formula, total brain AA accretion, expressed as absolute weight, was 5.0-fold greater from TG-AA than from PL-AA. We estimate that about half of postnatal brain AA accretion is derived from dietary preformed AA in term baboon neonates consuming a formula with lipid composition similar to that of human milk.


Subject(s)
Animals, Newborn/metabolism , Arachidonic Acid/pharmacokinetics , Brain/metabolism , Phosphatidylcholines/pharmacokinetics , Triglycerides/pharmacokinetics , Animals , Carbon Isotopes , Erythrocytes/metabolism , Female , Humans , Liver/metabolism , Lung/metabolism , Myocardium/metabolism , Organ Size , Papio , Pigment Epithelium of Eye/metabolism , Pregnancy , Retina/metabolism , Tissue Distribution
SELECTION OF CITATIONS
SEARCH DETAIL
...